Galmed Pharmaceuticals (GLMD) Priced

Clinical-stage biotech with a candidate for liver diseases (NASH).

Health Care - Biotechnology

IPO Performance
Latest Trade $4.19 0.00 (0.0%)
First Day Return 6.0%
Return from IPO -69.0%
 
Galmed Pharmaceuticals IPO News more
  • .
IPO Data
IPO File Date 02/06/2014
Offer Price $13.50
Price Range $12.00 - $14.00
Offer Shares (mm) 2.8
Deal Size ($mm) 38
 
IPO Data
IPO Date 03/12/2014
Offer Price $13.50
Price Range $12.00 - $14.00
Offer Shares (mm) 2.8
Deal Size ($mm) $38
 
Underwriters
more
Business Overview
Clinical-stage biotech with a candidate for liver diseases (NASH).
Clinical-stage biotech with a candidate for liver diseases (NASH).
more
Company Data
Headquarters Tel Aviv, , Israel
Founded 2000
Employees 10
Website www.galmedpharma.com
 

Performance vs. IPO Index (IPOUSA)